Prostate cancer Board decisions

The Board has granted service connection for prostate cancer and diabetes mellitus on a presumptive basis due to exposure to herbicide agents. The claims for urinary incontinence, erectile dysfunction, left breast removal, right breast removal, and hemochromatosis are remanded.

The Veteran's prostate cancer is granted service connection as it can be presumed to be related to his exposure to herbicide agents while serving in Thailand.

The Board has dismissed the Veteran's appeals for service connection for heart condition, prostate cancer, skin disorder (claimed as skin discoloration), and type II diabetes mellitus, all of which were claimed to be due to herbicide agent exposure. The appeal was dismissed because the appellant died during the pendency of the appeal.

The Board has determined that the Veteran's prostate cancer is not related to his service, including exposure to contaminated water at Camp Lejeune. The preponderance of evidence does not support a finding that the prostate cancer had its onset during active service or is otherwise related to an in-service injury or disease.

The Veteran's service-connected residuals of prostate cancer do not render him unemployable as he has been able to work in a managerial position and does not require any accommodations. The Board denied his claim for TDIU.

The Board has granted service connection for bladder cancer, prostate cancer, and diabetes mellitus type II. The Veteran's erectile dysfunction is remanded for further examination and opinion.

The Veteran's appeals for various conditions have been dismissed due to his death.

The Veteran's prostate cancer disability rating from 100% to 40% has been reduced. The Board is remanding the case due to outstanding private treatment records and a need for a VA urology opinion regarding the current severity of his prostate cancer.

The Board has remanded the issues of service connection for a prostate disability, claimed as prostatitis and prostate cancer; an acquired psychiatric disability (claimed as PTSD); and a chronic joint pain disability. The Veteran contends these disabilities are related to his military service in Vietnam.

The Board has remanded the Veteran's claims for service connection for prostate cancer and diabetes mellitus as secondary to herbicide exposure due to insufficient evidence of in-service herbicide agent exposure. The RO is instructed to attempt verification through JSRCC, issue a statement of the case on the diabetes mellitus claim, and readjudicate both issues.

The Veteran's claim for service connection for prostate cancer and its residuals was granted, with the decision being based on new evidence received since the final denial.

The Board has remanded the case due to incomplete records and further development is needed to determine if the Veteran was exposed to herbicides in Vietnam, which could affect his claim for service connection for the cause of his death.

The Veteran's prostate cancer is in remission and there is no evidence of renal dysfunction. The maximum schedular rating for prostate cancer has already been assigned, so a higher rating is not available.

The Veteran's service connection for prostate cancer is granted due to presumed exposure to herbicides during his active duty in the Korean DMZ.

The Board has determined that the Veteran's prostate cancer, obstructive sleep apnea, and thyroid cancer claims should be remanded for additional development due to a duty-to-assist error.

The Board has determined that the Veteran's prostate cancer is related to asbestos exposure during his military service and grants service connection for this condition.

The Veteran's prostate cancer residuals are being remanded for a new examination to reassess the severity of his disability, as his most recent VA examination is nearly 5 years old and he needs more treatment records.

The Board has remanded the Veteran's claims for service connection for prostate cancer and diabetes mellitus, type II due to exposure to herbicides at Fort McClellan in Alabama. The AOJ is instructed to verify the Veteran’s alleged exposure through appropriate development with the JSRRC.

The Veteran's prostatectomy scars were not shown to be painful or unstable and did not limit the function of the affected parts. Therefore, an initial compensable rating for these scars is denied prior to February 1, 2017.

The Board has determined that the Veteran's diabetes mellitus, type II and peripheral neuropathy of the bilateral upper and lower extremities did not manifest during or within one year of separation from service and are not otherwise related to service. Service connection for prostate cancer, bilateral hearing loss, tinnitus, status post pulmonary inflammatory pseudotumor, and allergic rhinitis is also denied as secondary to herbicide exposure.